Skip to Content

Prolacria Approval Status

  • FDA approved: No
  • Brand name: Prolacria
  • Generic name: diquafosol tetrasodium
  • Dosage form: Ophthalmic Solution
  • Company: Inspire Pharmaceuticals, Inc.
  • Treatment for: Dry Eye

Development Status and FDA Approval Process for Prolacria

DateArticle
Oct  5, 2006Inspire Continues Discussions with FDA on Dry Eye Program
Mar 28, 2006Inspire Announces Outcome of FDA Meeting on Dry Eye Program
Dec  2, 2005Inspire Announces Receipt of FDA Approvable Letter for Diquafosol
Jun  1, 2005Inspire Submits Amendment to New Drug Application for Diquafosol for the Treatment of Dry Eye
Jan 30, 2004Inspire Pharmaceuticals Announces Outcome of Meeting with the FDA on Diquafosol

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide